Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964743 · ClinicalTrials.gov registry record · NA
Depocyt® With Sorafenib in Neoplastic Meningitis
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00964743 is a NA study that was terminated before completion, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 2 participants.
The verdict
NCT00964743, a NA study, was terminated before completion, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the tolerability and side effects of oral sorafenib in combination with intrathecal DepoCyt.
Interventions
- DRUG Sorafenib
- DRUG DepoCyt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964743
The ClinicalTrials.gov registry entry for NCT00964743 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sorafenib is the first listed.
NCT00964743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964743 about?
NCT00964743 is a clinical study titled "Depocyt® With Sorafenib in Neoplastic Meningitis". The purpose of this study is to determine the tolerability and side effects of oral sorafenib in combination with intrathecal DepoCyt.
What is the current status of trial NCT00964743?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-08. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00964743?
The interventions under investigation include: Sorafenib (DRUG), DepoCyt (DRUG).
Who is sponsoring clinical trial NCT00964743?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.